2026. NEUROPHARMACOLOGICAL AND HEMODYNAMIC DIVERGENCE OF FIRST- VERSUS SECOND-GENERATION H1-RECEPTOR ANTAGONISTS: CLINICAL IMPLICATIONS IN ALLERGIC DERMATOSES. World Bulletin of Public Health. 56, (Mar. 2026), 89–92.